Marshall Wace, LLP
- SEC CIK
- 0001318757
- Latest filing
- Aug 13, 2026
TERN holding history
Terns Pharmaceuticals, Inc. in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TERN overviewAll 13F holders of TERNFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −927,600−100.0% | Sold out | Holders |
| Q1 2026 | 927,600 | $48.9M | 0.1% | +49,017+5.6% | Added | Holders |
| Q4 2025 | 878,583 | $35.5M | <0.1% | +878,583 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −144,644−100.0% | Sold out | Holders |
| Q1 2025 | 144,644 | $399.2K | <0.1% | −658,692−82.0% | Reduced | Holders |
| Q4 2024 | 803,336 | $4.45M | <0.1% | +698,578+666.8% | Added | Holders |
| Q3 2024 | 104,758 | $873.7K | <0.1% | +78,773+303.1% | Added | Holders |
| Q2 2024 | 25,985 | $177.0K | <0.1% | −160,024−86.0% | Reduced | Holders |
| Q1 2024 | 186,009 | $1.22M | <0.1% | +186,009 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −356,726−100.0% | Sold out | Holders |
| Q2 2023 | 356,726 | $3.12M | <0.1% | +171,698+92.8% | Added | Holders |
| Q1 2023 | 185,028 | $2.19M | <0.1% | +148,947+412.8% | Added | Holders |
| Q4 2022 | 36,081 | $367.3K | <0.1% | +36,081 | New | Holders |